United Therapeutics (UTHR) Tops Q1 EPS by 38c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $545.96 +0.10%
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.17, $0.38 better than the analyst estimate of $5.79. Revenue for the quarter came in at $677.7 million versus the consensus estimate of $620.31 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- MIND Technology (MIND) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
